tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Roche reports FY25 group sales CHF 61.52B vs. CHF 60.5B last year
PremiumThe FlyRoche reports FY25 group sales CHF 61.52B vs. CHF 60.5B last year
13d ago
Roche board proposes dividend increase to CHF 9.80 per share
Premium
The Fly
Roche board proposes dividend increase to CHF 9.80 per share
13d ago
Roche expects increase in group sales in mid single digit range for FY26
Premium
The Fly
Roche expects increase in group sales in mid single digit range for FY26
13d ago
Drugmakers concerned about legal risk with FDA review program, Reuters reports
PremiumThe FlyDrugmakers concerned about legal risk with FDA review program, Reuters reports
26d ago
Roche: Clinical Momentum Improves Outlook but Valuation Keeps Risk/Reward Balanced at Hold
Premium
Ratings
Roche: Clinical Momentum Improves Outlook but Valuation Keeps Risk/Reward Balanced at Hold
26d ago
Roche upgraded to Neutral from Sell at Goldman Sachs
Premium
The Fly
Roche upgraded to Neutral from Sell at Goldman Sachs
27d ago
Trump Trade: Trump administration moves to end pharma trade probe
PremiumThe FlyTrump Trade: Trump administration moves to end pharma trade probe
28d ago
Trump administration moves to end U.S. pharma trade probe, Endpoints News says
Premium
The Fly
Trump administration moves to end U.S. pharma trade probe, Endpoints News says
29d ago
Roche upgraded to Overweight at Barclays on valuation, clinical catalysts
Premium
The Fly
Roche upgraded to Overweight at Barclays on valuation, clinical catalysts
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100